DEVIN HAUB: Open Payments
NPI 1952835910 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 42 payments from 14 companies in 2025. Trend: 2023 $1,139 · 2024 $854 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| PFIZER INC. | 4 | $88 |
| Lilly USA, LLC | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $19 |
| Sage Therapeutics, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
Products named: UBRELVY, VRAYLAR, NURTEC ODT, MOUNJARO, BREZTRI, Auvelity, QULIPTA, Kerendia.
Industry payments across IL — which companies pay providers there.
